Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system …
Over the last 12 months, insiders at Viatris Inc. have bought $0 and sold $15.86M worth of Viatris Inc. stock.
On average, over the past 5 years, insiders at Viatris Inc. have bought $558,372 and sold $8.13M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 19 shares for transaction amount of $171 was made by KORMAN HARRY (director) on 2023‑10‑26.
2024-11-11 | Sale | See Remarks | 26,925 0.0022% | $12.88 | $346,686 | -4.51% | ||
2024-09-12 | Sale | director | 200,000 0.0166% | $11.67 | $2.33M | +0.60% | ||
2024-08-30 | Sale | director | 50,000 0.0042% | $12.00 | $600,000 | -2.40% | ||
2024-08-28 | Sale | director | 50,000 0.0042% | $11.90 | $595,075 | -0.80% | ||
2024-08-23 | Sale | director | 100,000 0.0084% | $11.75 | $1.18M | +0.34% | ||
2024-08-22 | Sale | director | 100,000 0.0084% | $11.73 | $1.17M | +0.77% | ||
2024-08-21 | Sale | director | 100,000 0.0084% | $11.75 | $1.18M | +0.51% | ||
2024-06-14 | Sale | director | 264,300 0.0212% | $10.18 | $2.69M | +15.63% | ||
2024-06-13 | Sale | director | 85,660 0.0071% | $10.52 | $900,741 | +13.14% | ||
2024-05-28 | Sale | Chief Legal Officer | 89,419 0.0075% | $10.38 | $928,429 | +12.76% | ||
2024-03-13 | Sale | See Remarks | 250,000 0.0211% | $12.09 | $3.02M | -3.15% | ||
2024-03-05 | Sale | See Remarks | 24,353 0.0021% | $12.33 | $300,272 | -4.76% | ||
2024-03-05 | Sale | director | 20,000 0.0017% | $12.36 | $247,200 | -4.76% | ||
2024-03-04 | Sale | President, Greater China | 21,532 0.0018% | $12.51 | $269,314 | -5.26% | ||
2024-02-23 | Sale | See Remarks | 4,000 0.0003% | $13.50 | $54,000 | -13.38% | ||
2024-02-15 | Sale | See Remarks | 4,000 0.0003% | $12.50 | $50,000 | -8.39% | ||
2024-01-04 | Sale | See Remarks | 4,000 0.0003% | $11.50 | $46,000 | +1.51% | ||
2023-12-14 | Sale | See Remarks | 4,000 0.0003% | $10.50 | $42,000 | +12.99% | ||
2023-11-24 | Sale | President, Greater China | 14,937 0.0012% | $9.37 | $139,942 | +23.30% | ||
2023-10-26 | director | 19 <0.0001% | $9.01 | $171 | +28.59% |
GOETTLER MICHAEL | Chief Executive Officer | 136796 0.0115% | $10.95 | 1 | 0 | +8.94% |
KORMAN HARRY | director | 94960 0.008% | $10.95 | 10 | 0 | |
KILTS JAMES M | director | 64905 0.0054% | $10.95 | 1 | 0 | <0.0001% |
CORNWELL W DON | 22031 0.0018% | $10.95 | 4 | 0 | <0.0001% |
Increased Positions | 405 | +35.5% | 89M | +9.53% |
Decreased Positions | 470 | -41.19% | 37M | -3.92% |
New Positions | 85 | New | 6M | New |
Sold Out Positions | 88 | Sold Out | 4M | Sold Out |
Total Postitions | 1,076 | -5.7% | 987M | +5.61% |
Vanguard Group Inc | $1.59M | 11.81% | 141.03M | +702,654 | +0.5% | 2024-09-30 |
Blackrock, Inc. | $1.06M | 7.88% | 94.03M | +1M | +1.47% | 2024-09-30 |
State Street Corp | $711,948.00 | 5.29% | 63.12M | +1M | +1.62% | 2024-09-30 |
Davis Selected Advisers | $706,661.00 | 5.25% | 62.65M | +5M | +8.88% | 2024-09-30 |
Price T Rowe Associates Inc /Md/ | $550,297.00 | 4.09% | 48.79M | -8M | -14.14% | 2024-09-30 |
Pacer Advisors, Inc. | $396,527.00 | 2.94% | 35.15M | +35M | +30,518.5% | 2024-12-31 |
Invesco Ltd. | $344,537.00 | 2.56% | 30.54M | -169,516 | -0.55% | 2024-09-30 |
Geode Capital Management, Llc | $332,044.00 | 2.47% | 29.44M | +439,584 | +1.52% | 2024-09-30 |
Deerfield Management Company, L.P. (Series C) | $270,641.00 | 2.01% | 23.99M | +3M | +12.14% | 2024-09-30 |
Ameriprise Financial Inc | $244,847.00 | 1.82% | 21.71M | -154,381 | -0.71% | 2024-09-30 |